Capricor Therapeutics, Inc.
Capricor Therapeutics, Inc. (CAPR) Stock Ownership
Institutional vs insider vs public ownership from 13F and float data — top holders, activity, and insider trades below.
SEC 13F · FMP · CAPR · as of Sep 30, 2025
Ownership Breakdown
141
Institutional Holders
▲ 5 vs Q2
$104.37M
Total Inst. Value
▼ $32.14M vs Q2
45.72M
Shares Outstanding
freeFloat 82.69%
14.49M
13F Shares Held
▲ 752,195 vs Q2
Institutional ownership = 13F shares ÷ total outstanding. Insider % = 100 − free float. Public % = free float − institution %. Data: FMP /symbol-positions-summary + /shares-float + SEC EDGAR.
Top Institutional Holders
CAPR largest shareholders · institutional ownership
Q3 2025 · SEC 13F
Showing top 10 holders
| Holder | Shares | % Owned | Weight | Value | Reported | Change |
|---|---|---|---|---|---|---|
BLACKROCK, INC. pharmaceutical preparations | 2.87M | 6.28% | 6.28% | $20.69B | Nov 12, 2025 | ▼ 113.9K |
VANGUARD GROUP INC pharmaceutical preparations | 2.21M | 4.83% | 4.83% | $15.91B | Nov 7, 2025 | ▼ 98.4K |
SUSQUEHANNA INTERNATIONAL GROUP, LLP pharmaceutical preparations | 1.23M | 2.69% | 2.69% | $8.87B | Nov 14, 2025 | ▼ 155.7K |
GEODE CAPITAL MANAGEMENT, LLC pharmaceutical preparations | 961.6K | 2.10% | 2.10% | $6.93B | Nov 12, 2025 | ▼ 1.5K |
STATE STREET CORP pharmaceutical preparations | 801.3K | 1.75% | 1.75% | $5.78B | Nov 14, 2025 | ▼ 665.3K |
CITADEL ADVISORS LLC pharmaceutical preparations | 752.9K | 1.65% | 1.65% | $5.43B | Nov 14, 2025 | ▲ 319.1K |
CITADEL ADVISORS LLC pharmaceutical preparations | 745.6K | 1.63% | 1.63% | $5.38B | Nov 14, 2025 | ▲ 443.6K |
SUSQUEHANNA INTERNATIONAL GROUP, LLP pharmaceutical preparations | 615.9K | 1.35% | 1.35% | $4.44B | Nov 14, 2025 | ▼ 306.8K |
MORGAN STANLEY pharmaceutical preparations | 551.7K | 1.21% | 1.21% | $3.98B | May 27, 2026 | ▲ 1.1K |
PIER CAPITAL, LLC pharmaceutical preparations | 496.6K | 1.09% | 1.09% | $3.58B | Nov 13, 2025 | ▲ 128.8K |
Data from SEC Form 13F filings. Ownership bar normalised to largest holder. Change flags: isNew / isSoldOut / changeInSharesNumber (FMP extract-analytics/holder).
Institutional Activity
Q3 2025 vs prior quarter
Q3 2025
20
Increased
+2.48M shares10
New Positions
first time holders17
Decreased
−4.17M shares0
Sold Out
fully exitedNet shares change (top 50)
1.70M
+2.48M / −4.17M
Net new holders
+13
10 new / 0 exited
Based on top 50 institutional holders by position size. Fields: isNew, isSoldOut, changeInSharesNumber (FMP extract-analytics/holder, limit=50).
Insider Buying vs Selling
CAPR insider trading · insider activity
Source: SEC Form 4
Insiders have been primarily selling shares recently. Selling may be driven by pre-scheduled Rule 10b5-1 plans rather than negative sentiment.
6
Buy transactions
10
Sell transactions
0.60
Buy/Sell ratio
$0M
Total disposed
Recent Insider Transactions
Showing 10 most recent · Common Stock only
| Name · Role | Date | Type | Shares | Price | Value | After Trans. | Filing |
|---|---|---|---|---|---|---|---|
Maurer Michael T CHIEF COMMERCIAL OFFICER | May 26, 2026 | Award | 80,000 | $29.36 | $2.35M | 80.0K | Form 4 ↗ |
Krasney Karen EVP, GENERAL COUNSEL | May 1, 2026 | Sale | 25,000 | $31.70 | $792.5K | 30.5K | Form 4 ↗ |
Bergmann Anthony CHIEF FINANCIAL OFFICER | May 1, 2026 | Sale | 25,000 | $31.70 | $792.5K | 8.2K | Form 4 ↗ |
Sabar Karimah Es director | Apr 2, 2026 | Sale | 7,529 | $32.00 | $240.9K | 0 | Form 4 ↗ |
Source: /insider-trading/search (FMP stable). Buy/Sell direction: acquisitionOrDisposition A=Buy, D=Sell. RSU vesting (M-Exempt) excluded from sentiment bar. All data from SEC EDGAR public filings.
About institutional & insider ownership
Capricor Therapeutics, Inc. (CAPR) is primarily owned by institutional investors, who hold approximately 31.7% of total shares outstanding. Company insiders own approximately 17.31%, while retail and public investors account for the remaining 50.99%.
The largest institutional shareholder of Capricor Therapeutics, Inc. is BLACKROCK, INC., holding approximately 2.87 million shares — equal to 6.28% of outstanding shares — as of September 30, 2025.
A total of 141 institutional investors currently hold CAPR stock, with a combined institutional value of approximately $104,372,318 as of the most recent 13F filing period.
Frequently asked questions
CAPR ownershipCapricor Therapeutics, Inc. (CAPR) is primarily owned by institutional investors, who hold approximately 31.7% of shares. The largest shareholder is BLACKROCK, INC. with a 6.28% stake. Company insiders hold 17.31%. Data sourced from SEC Form 13F as of September 30, 2025.